Additionally, the expression of BTG2 is significantly correlated with the degree of tumor differentiation, indicating that ESCC patients with low BTG2 expression tend to have poorly differentiated tumors. The gene discussed is BTG2; the disease is esophageal squamous cell carcinoma.